Ayuda
Ir al contenido

Dialnet


Resumen de Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes

Giovanni Targher, Giacomo Zoppini, William Mantovani, Michel Chonchol, Carlo Negri, Vincenzo Stoico, Alessandro Mantovani, Francesca De Santi, Enzo Bonora

  • To compare the performance of two glomerular filtration rate (GFR)-estimating equations in predicting the risk of all-cause and cardiovascular mortality in type 2 diabetic patients. We followed 2,823 type 2 diabetic outpatients for a period of 6 years for the occurrence of all-cause and cardiovascular mortality. GFR was estimated using the four-variable Modification of Diet in Renal Disease (MDRD) study equation and the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. At baseline, an estimated GFR (eGFR) <60 mL/min/1.73 m^sup 2^ was present in 22.0 and 20.2% of patients using the MDRD study equation and the CKD-EPI equation, respectively. A total of 309 patients died during the follow-up (152 patients from cardiovascular causes). Both creatinine-based equations were associated with an increased risk of all-cause and cardiovascular mortality. However, the CKD-EPI equation provided a more accurate risk prediction of mortality than the MDRD study equation. Receiving operating characteristic curves showed that the areas under the curve (AUCs) for all-cause mortality (AUC 0.712 [95% CI 0.682-0.741]) and cardiovascular mortality (0.771 [0.734-0.808]) using eGFR^sub CKD-EPI^ were significantly greater (P < 0.0001 by the z statistic) than those obtained by using eGFR^sub MDRD^ (0.679 [0.647-0.711] for all-cause mortality and 0.739 [0.698-0.783] for cardiovascular mortality). Our findings suggest that the estimation of GFR using the CKD-EPI equation more appropriately stratifies patients with type 2 diabetes according to the risk of all-cause and cardiovascular mortality compared with the MDRD study equation. [PUBLICATION ABSTRACT]


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus